why choose us

First received: November 17, 2024

Clinical Trial: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Ischemic Stroke

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (CAPTAIN)--A Multicenter, Prospective, Randomized Trial

Brief Summary: This study is an investigator-initiated, multicenter, prospective, open-label, endpoint-blinded, randomized controlled trial (PROBE design) that includes patients with moderate or severe symptomatic intracranial large vessel atherosclerotic stenosis (sICAS) who present with acute ischemic stroke within 48 hours of symptom onset.Patients will be centrally randomized in a 1:1 ratio into two groups:Experimental Group: A single subcutaneous injection of 420 mg evolocumab upon admission, combined with standard doses of…

Read more